Showing results (1041-1050 of 2,639) with videos related to

Sort By:
Pageof 264
Plastic and Reconstructive Surgery|April 6, 1999
Evaluation of bone height in osseous free flap mandible reconstruction: an indirect measure of bone massJ J Disa, D A Hidalgo, P G Cordeiro, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 30, 2016
Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study resultsHervé Fernandez, Torsten Schmidt, Martin Powell, et al.
Molecular Metabolism|April 6, 2017
Astrocyte IKKβ/NF-κB signaling is required for diet-induced obesity and hypothalamic inflammationJ D Douglass, M D Dorfman, R Fasnacht, et al.
Pediatrics|September 1, 1992
Growth and development of children conceived by in vitro fertilizationJ M Brandes, A Scher, J Itzkovits, et al.
Blood|February 1, 1983
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritinsL Lu, H E Broxmeyer, P A Meyers, et al.
Experimental Brain Research|January 1, 1995
The functions of the medial premotor cortex. II. The timing and selection of learned movementsY C Chen, D Thaler, P D Nixon, et al.
Journal of the Neurological Sciences|October 20, 2022
The interplay between structural and functional connectivity in early stage Parkinson's disease patientsAmgad Droby, Shai Nosatzki, Yariv Edry, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2012
Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysisAnna Glechner, Achim Wöckel, Gerald Gartlehner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognitionB T Messmer, J J Sullivan, N Chiorazzi, et al.
Annals of Hematology|December 19, 1998
Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia--results of a phase-II trialF Schneller, M Schuler, K Schumacher, et al.
Pageof 264